Paraneoplastic neurological syndromes

por Leypoldt, F, Wandinger, K-P
Publicado 2014

Successful immunosuppressive treatment and long‐term follow‐up of anti‐Ri‐associated paraneoplastic myelitis

por Leypoldt, F, Eichhorn, P, Saager, C, Münchau, A, Lewerenz, J
Publicado 2006

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

por Jarius, S., Ruprecht, K., Stellmann, J. P., Huss, A., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., Leypoldt, F., Haas, J., Kleiter, I., Tumani, H., Fechner, K., Reindl, M., Paul, F., Wildemann, B.
Publicado en J Neuroinflammation (2018)

S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)

por Tumani, H., Petereit, H. F., Gerritzen, A., Gross, C. C., Huss, A., Isenmann, S., Jesse, S., Khalil, M., Lewczuk, P., Lewerenz, J., Leypoldt, F., Melzer, N., Meuth, S. G., Otto, M., Ruprecht, K., Sindern, E., Spreer, A., Stangel, M., Strik, H., Uhr, M., Vogelgsang, J., Wandinger, K.-P., Weber, T., Wick, M., Wildemann, B., Wiltfang, J., Woitalla, D., Zerr, I., Zimmermann, T.
Publicado en Neurol Res Pract (2020)